WIRB-Copernicus Group Launches Oncology IRB to Meet Challenges of Cancer Research

The WIRB-Copernicus Group (WCG), a large provider of regulatory and ethical review services for clinical research, has formed WCG Oncology, a new cancer-focused institutional review board, along with the WCG Oncology Expert Advisory Board, which includes James E. Rothman, Ph.D., the 2013 recipient of the Nobel Prize in Medicine and chairman of cell biology at Yale Medical School.

Publication: CenterWatch News Online

To read this article, please click here.